$INDI

Parekh Sonalee Elizabeth sold $76K of INDI

Parekh Sonalee Elizabeth sold 20,000 shares of indie Semiconductor, Inc. (INDI) at $3.80 on 2026-08-12.

Original reporting
SEC EDGAR · Parekh Sonalee Elizabeth
Published Aug 14, 2026, 10:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 14, 2026, 10:11 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$INDI
Neutral
medium confidence
Mentioned
$INDI
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$INDINeutralLow
01

Why it matters

The newest fact is the director’s open-market sale details (20,000 shares at $3.80, $76,000 total) and post-transaction holdings (159,789 shares).

02

Market read

Traders may monitor insider activity, but this specific disclosure lacks accompanying fundamental news.

03

What to watch

The filing does not state a 10b5-1 plan and does not provide context for the sale (taxes, diversification, planned spending), limiting interpretability.

Relevance 3/10Novelty 4/10Timing: Filed on 2026-08-14 after-hours; reflects sale executed 2026-08-12.

Background

The article is an SEC Form 4 insider transaction disclosure for indie Semiconductor, Inc. (INDI).

Company-level read

Ticker impact

$INDINeutralMedium confidence
Context

Director Parekh Sonalee Elizabeth filed a Form 4 open-market sale of 20,000 INDI shares at $3.80 on 2026-08-12.

Expected impact

Low likelihood of sustained price impact; any reaction is likely short-lived unless paired with other negative company news.

Evidence & confidence

The filing is a director open-market sale with no 10b5-1 plan stated, but the article provides no new operational, financial, or regulatory catalyst beyond the transaction itself.

Market effects

No sector-wide implications; this is a single-company insider transaction.

None indicated.

None indicated.

Counterpoint

Insider sales can be driven by diversification or liquidity needs and may not reflect bearish expectations.

Key entities

  • INDI

    indie Semiconductor, Inc., the company whose director sold shares via an open-market sale.

  • Parekh Sonalee Elizabeth

    Director who reported the sale on SEC Form 4.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$KRMNMed

OC Aerospace, Tech Companies Report Booming Sales

Karman Holdings (NYSE: KRMN) raised its FY2026 revenue outlook to $730M-$745M after Q2 revenue rose 58% to $182M, beating expectations. The article also summarizes earnings for TTM Technologies (TTMI), Viant Technology (DSP), Ducommun (DCO), Indie Semiconductor (INDI), and Clean Energy Fuels (CLNE), citing revenue and guidance figures.

$INDIMedAI 8/10

Indie Semi Jumps on Revenue Increase

Indie Semiconductor (Nasdaq: INDI) shares rose 16% to $4.00 in after-hours after reporting 24% higher Q2 revenue versus the same period in 2025. For the current quarter, it expects revenue of $67 million to $73 million, implying about 30% YoY growth at the midpoint.

$INDIHigh

indie Semiconductor, Inc. (INDI): Results of Operations and Financial Condition

indie Semiconductor, Inc. (INDI) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 indie Reports Second Quarter 2026 Results • Delivers Revenue of $64M, up 24% Y-o-Y and exceeds midpoint of the guidance range • Guides for accelerating growth of 30% Y-o-Y in Q3 2026 • Substantially narrows GAAP and Non-GAAP Operating Losses • Gains global OEM adopti

$HIVEMedAI 8/10

Investors’ Stock Portfolio: Top 10 Penny Stocks To Buy

The article says US small-cap and penny stocks are benefiting from AI-driven risk appetite, citing the Russell 2000’s 16% YTD outperformance. It lists “Top 10” penny stocks under $5, using S&P 500 10% YTD outperformance, >20% upside, and hedge-fund holdings. For HIVE (share $4.54), it reports FY2026 revenue $297.8M (+158%) and adjusted EBITDA $72.9M. For indie Semiconductor (share $4.93), Benchmark reiterates Buy and an $8 target after a €40M acquisition of ams OSRAM’s CMOS image sensor business